Julia R. Douglas-Dixon

305 Grattan St
Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.

Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.

Journal: The Lancet. Oncology

Published: November 17, 2025

Genomic landscape of metastatic breast cancers in young adults: a liquid biopsy analysis of women aged 20-40 years.

Genomic landscape of metastatic breast cancers in young adults: a liquid biopsy analysis of women aged 20-40 years.

Journal: Breast (Edinburgh, Scotland)

Published: October 17, 2025

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 26, 2025

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 26, 2025

Rb-driven transcription limits its tumour-suppressive effects in breast cancer.

Rb-driven transcription limits its tumour-suppressive effects in breast cancer.

Journal: Nature

Published: August 26, 2025

Baseline tumour burden and prognosis in breast cancer treated with immune checkpoint inhibitors.

Baseline tumour burden and prognosis in breast cancer treated with immune checkpoint inhibitors.

Journal: Breast (Edinburgh, Scotland)

Published: March 19, 2025

Unveiling the Potential of Cyclin-Dependent Kinases 4 and 6 Inhibitors Beyond Progression in Hormone Receptor Positive/Human Epidermal Growth Factor Negative Advanced Breast Cancer - A Clinical Review.

Unveiling the Potential of Cyclin-Dependent Kinases 4 and 6 Inhibitors Beyond Progression in Hormone Receptor Positive/Human Epidermal Growth Factor Negative Advanced Breast Cancer - A Clinical Review.

Journal: Current treatment options in oncology

Published: August 21, 2024

Sustained lymphocyte decreases after treatment for early breast cancer.

Sustained lymphocyte decreases after treatment for early breast cancer.

Journal: NPJ breast cancer

Published: March 26, 2024

Moving to ultra-short therapy to cure patients with cancer: a solution for sustainable cancer care.

Moving to ultra-short therapy to cure patients with cancer: a solution for sustainable cancer care.

Journal: ESMO open

Published: August 21, 2023

Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?

Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?

Journal: Current treatment options in oncology

Published: March 19, 2023

Integrating Immunotherapy Into the Treatment Landscape for Patients With Triple-Negative Breast Cancer.

Integrating Immunotherapy Into the Treatment Landscape for Patients With Triple-Negative Breast Cancer.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Published: June 01, 2022

Triplet Therapy in Melanoma - Combined BRAF/MEK Inhibitors and Anti-PD-(L)1 Antibodies.

Triplet Therapy in Melanoma - Combined BRAF/MEK Inhibitors and Anti-PD-(L)1 Antibodies.

Journal: Current oncology reports

Published: December 03, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026